Journal article Open Access
N.Tejaswi1*, Y.Triveni1, M.Indira Priyadarshini1, Dr.A.Satish Kumar2, P.Sharmila Nirojini1, M.Maneesh Kumar1, Prof.Rama Rao Nadendla1
The aim of the study was to evaluate the impact of clinical pharmacist care on Quality of life in cervical cancer patients treated with either Radiotherapy alone or in combination with Chemotherapy. An observational prospective study was conducted over a period of 6 months i.e., from January to July 2016 in the Department of Radiotherapy, GGH, Guntur. The EORTC QLQ-C30 3.0 version, EORTC QLQ CX24 was used to assess the patients quality of life at three different stages i.e., before, after treatment & during follow up. Patients were counseled about disease, therapy & its side effects management. The results were evaluated using one way ANOVA, unpaired t test in graph pad prism version (5.04).A total of 66 patients were enrolled in the study. The mean score of global health of cervical cancer patients during follow up was 85.66±12.26, which was significantly higher than the before treatment score 45.88±12.24 (P value <0.0001).There was also significant improvement in functional domain scales like physical function, role function, emotional function, social function and cognitive function. Mean symptoms score at follow up was 6.90 ±23.03 was declined compared to before treatment scores 31.93±23.5 (P value <0.0001). Patients complain of substantial decline in sexual activity post radiotherapy. There was a significant improvement in quality of life in cervical carcinoma patients after treatment with radiotherapy and chemotherapy along with clinical pharmacist counseling.